We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01670877
Brief Title: Neratinib +/- Fulvestrant in Metastatic HER2 Non-amplified But HER2 Mutant Breast Cancer

First Submitted : August 17, 2012
First Submitted that Met QC Criteria : August 17, 2012
First Posted : August 22, 2012 (Estimate)

Last Update Submitted : February 8, 2018
Last Update Submitted that Met QC Criteria : February 8, 2018
Last Update Posted : February 12, 2018